{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:08Z","timestamp":1786979888440,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00259-021-05592-w","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T23:15:45Z","timestamp":1635117345000},"page":"1607-1612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Can Q.Clear reconstruction be used to improve [68\u00a0Ga]Ga-DOTANOC PET\/CT image quality in overweight NEN patients?"],"prefix":"10.1007","volume":"49","author":[{"given":"Lucia","family":"Zanoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-4146","authenticated-orcid":false,"given":"Giulia","family":"Argalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Fortunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Malizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Civollani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"5592_CR1","unstructured":"Obesity and overweight. In World Health Organization. 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 3 Aug 2021"},{"key":"5592_CR2","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.113.130393","author":"R S\u00e1nchez-Jurado","year":"2014","unstructured":"S\u00e1nchez-Jurado R, Devis M, Sanz R, Aguilar JE, del Puig CM, Ferrer-Rebolleda J. Whole-body PET\/CT studies with lowered 18F-FDG doses: the influence of body mass index in dose reduction. J Nucl Med Technol. 2014. https:\/\/doi.org\/10.2967\/jnmt.113.130393.","journal-title":"J Nucl Med Technol"},{"key":"5592_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s0025900209805","author":"M Tatsumi","year":"2003","unstructured":"Tatsumi M, Clark PA, Nakamoto Y, Wahl RL. Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET. Eur J Nucl Med Mol Imaging. 2003. https:\/\/doi.org\/10.1007\/s0025900209805.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5592_CR4","unstructured":"In GE Healthcare. 2021. https:\/\/www.gehealthcare.com. Accessed 3 Aug 2021"},{"key":"5592_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2015.06.025","author":"N Parvizi","year":"2015","unstructured":"Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases? Eur J Radiol. 2015. https:\/\/doi.org\/10.1016\/j.ejrad.2015.06.025.","journal-title":"Eur J Radiol"},{"key":"5592_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4253-2","author":"EJ Teoh","year":"2016","unstructured":"Teoh EJ, McGowan DR, Bradley KM, et al. 18F-FDG PET\/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction. Eur Radiol. 2016. https:\/\/doi.org\/10.1007\/s00330-016-4253-2.","journal-title":"Eur Radiol"},{"key":"5592_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000604","author":"BR Sah","year":"2017","unstructured":"Sah BR, Stolzmann P, Delso G, et al. Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET\/CT studies. Nucl Med Commun. 2017. https:\/\/doi.org\/10.1097\/MNM.0000000000000604.","journal-title":"Nucl Med Commun"},{"key":"5592_CR8","doi-asserted-by":"publisher","unstructured":"Wyrzykowski M, Siminiak N, Ka\u017amierczak M, Rucha\u0142a M, Czepczy\u0144ski R. Impact of the Q.Clear reconstruction algorithm on the interpretation of PET\/CT images in patients with lymphoma.\u00a0EJNMMI. 2020; https:\/\/doi.org\/10.1186\/s13550-020-00690-6.","DOI":"10.1186\/s13550-020-00690-6"},{"key":"5592_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3728-y","author":"MF Bozkurt","year":"2017","unstructured":"Bozkurt MF, Virgolini I, Balogova S, et al. Guideline for PET\/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA. Eur J Nucl Med Mol Imaging. 2017. https:\/\/doi.org\/10.1007\/s00259-017-3728-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5592_CR10","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210043","author":"S Usmani","year":"2021","unstructured":"Usmani S, Ahmed N, Gnanasegaran G, et al. The clinical effectiveness of reconstructing 18F-sodium fluoride PET\/CT bone using Bayesian penalized likelihood algorithm for evaluation of metastatic bone disease in obese patients. Br J Radiol. 2021. https:\/\/doi.org\/10.1259\/bjr.20210043.","journal-title":"Br J Radiol"},{"key":"5592_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-020-00310-1","author":"E Lindstr\u00f6m","year":"2020","unstructured":"Lindstr\u00f6m E, Lindsj\u00f6 L, Sundin A, S\u00f6rensen J, Lubberink M. Evaluation of block-sequential regularized expectation maximization reconstruction of 68Ga-DOTATOC, 18F-fluoride, and 11C-acetate whole-body examinations acquired on a digital time-of-flight PET\/CT scanner. EJNMMI Phys. 2020. https:\/\/doi.org\/10.1186\/s40658-020-00310-1.","journal-title":"EJNMMI Phys"},{"key":"5592_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061100","author":"MJ Roef","year":"2021","unstructured":"Roef MJ, Rijnsdorp S, Brouwer C, Wyndaele DN, Arends AJ. Evaluation of quantitative Ga-68 PSMA PET\/CT repeatability of recurrent prostate cancer lesions using both OSEM and Bayesian penalized likelihood reconstruction algorithms. Diagnostics (Basel). 2021. https:\/\/doi.org\/10.3390\/diagnostics11061100.","journal-title":"Diagnostics (Basel)"},{"key":"5592_CR13","doi-asserted-by":"publisher","unstructured":"Teoh EJ, McGowan DR, Schuster DM, Tsakok MT, Gleeson FV, Bradley KM. Bayesian penalised likelihood reconstruction (Q.Clear) of\u00a018F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.\u00a0Br J Radiol. 2018; https:\/\/doi.org\/10.1259\/bjr.20170727","DOI":"10.1259\/bjr.20170727"},{"key":"5592_CR14","doi-asserted-by":"publisher","unstructured":"Teoh EJ, McGowan DR, Macpherson RE, Bradley KM, Gleeson FV. Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET\/CT System.\u00a0J Nucl Med. 2015; https:\/\/doi.org\/10.2967\/jnumed.115.159301","DOI":"10.2967\/jnumed.115.159301"},{"key":"5592_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-019-00594-x","author":"A Matti","year":"2019","unstructured":"Matti A, Lima GM, Pettinato C, Pietrobon F, Martinelli F, Fanti S. How do the more recent reconstruction algorithms affect the interpretation criteria of PET\/CT images? Nucl Med Mol Imaging. 2019. https:\/\/doi.org\/10.1007\/s13139-019-00594-x.","journal-title":"Nucl Med Mol Imaging"},{"key":"5592_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-019-01433-x","author":"E Witkowska-Patena","year":"2020","unstructured":"Witkowska-Patena E, Budzy\u0144ska A, Gi\u017cewska A, Dziuk M, Wal\u0119cka-Mazur A. Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET\/CT. Ann Nucl Med. 2020. https:\/\/doi.org\/10.1007\/s12149-019-01433-x.","journal-title":"Ann Nucl Med"},{"key":"5592_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-021-00359-6","author":"A Chicheportiche","year":"2021","unstructured":"Chicheportiche A, Goshen E, Godefroy J, et al. Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in 68Ga-DOTATATE PET\/CT studies? EJNMMI Phys. 2021. https:\/\/doi.org\/10.1186\/s40658-021-00359-6.","journal-title":"EJNMMI Phys"},{"key":"5592_CR18","unstructured":"Lantos J, Mittra ES, Levin CS, Iagaru A. Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticals. Am J Nucl Med Mol Imaging.\u00a02018;8(2):110\u201318."},{"key":"5592_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-017-0179-2","author":"S Adler","year":"2017","unstructured":"Adler S, Seidel J, Choyke P, Knopp MV, Binzel K, Zhang J, Barker C, Conant S, Maass-Moreno R. Minimum lesion detectability as a measure of PET system performance. EJNMMI Phys. 2017. https:\/\/doi.org\/10.1186\/s40658-017-0179-2.","journal-title":"EJNMMI Phys"},{"key":"5592_CR20","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.4923","author":"MC Adams","year":"2010","unstructured":"Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010. https:\/\/doi.org\/10.2214\/AJR.10.4923 Erratum in: AJR Am J Roentgenol. 2010.","journal-title":"AJR Am J Roentgenol"},{"key":"5592_CR21","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2304-3865.2014.11.03","author":"BD Cheson","year":"2015","unstructured":"Cheson BD. Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol. 2015. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2014.11.03.","journal-title":"Chin Clin Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05592-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05592-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05592-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T07:04:24Z","timestamp":1647932664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05592-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5592"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05592-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures, performed in studies involving human participants, were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Ethics Committee (electronic archive 131\/2017\/O\/Oss). Informed consent to participate was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"SF reports personal fees from ANMI, Astellas, Bayer, BlueEarth Diagnostics, GE Healthcare, Jenssen, Novartis, Sofie Biosciences, non-financial support from AAA, Bayer, GE Healthcare, Curium, Tema Sinergie, Sanofi, Telix, outside the submitted work; VAmbrosini reports personal fees from ESMIT and AAA outside the submitted work and is a member of ENETS advisory board, EANM oncology and theranostic commitee, ESMO faculty staff for NET and the scientific board of ITANET; DCalabr\u00f2 reports personal fees from ESMIT outside the submitted work; LZ reports personal fees from ESMIT and Springer outside the submitted work. DCampana, EF, GA, CM, VAllegri and SC declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}